Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.

T. Maitre (Paris, France), J. Cottenet (Dijon, France), C. Godet (Paris, France), P. Bonniaud (Dijon, France), C. Quantin (Dijon, France), J. Cadranel (Paris, France)

Source: International Congress 2019 – Clinical challenges in respiratory infection
Session: Clinical challenges in respiratory infection
Session type: Thematic Poster
Number: 4556
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Maitre (Paris, France), J. Cottenet (Dijon, France), C. Godet (Paris, France), P. Bonniaud (Dijon, France), C. Quantin (Dijon, France), J. Cadranel (Paris, France). Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.. 4556

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010


Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan.
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018


Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



An epidemiological study of chronic obstructive pulmonary disease (COPD) in a rural town of Japan: a one-year follow-up study
Source: Eur Respir J 2006; 28: Suppl. 50, 448s
Year: 2006

Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database
Source: Eur Respir J, 52 (3) 1800359; 10.1183/13993003.00359-2018
Year: 2018



Hemoptysis in adults: A 5-year study using the French nationwide hospital administrative database
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015


PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019




The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006

AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eCOPD) in Spain. Experience on mechanical ventilation in patients admitted for eCOPD. Pilot study in six autonomous regions
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009


Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020
Year: 2021



Prevalence and risk factors for pulmonary aspergillosis infection in thoracic oncology: a 5 years retrospective study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


15-Year mortality after hospitalization for COPD in a Dutch teaching hospital: Preliminary data from the MORTCOP cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Betablocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.4 million individuals
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019